Literature DB >> 28198711

Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014.

Laurence Brunet1, Sonia Napravnik, Amy D Heine, Peter A Leone, Joseph J Eron.   

Abstract

Longitudinal opioid prescription use is unknown among HIV-infected patients. Group-based trajectory modeling followed by multinomial logistic regression was used to identify distinct trajectories and their association with baseline characteristics among 1239 HIV-infected UNC CFAR HIV Clinical Cohort participants, 2000-2014. Three trajectories were identified: (1) 72% never/sporadic opioid use (referent group), (2) 11% episodic use (associated with female sex, depression, drug-related diagnoses, antiretroviral therapy use, and undetectable HIV RNA), and (3) 16% chronic use (associated with older age, female sex, and mental health diagnoses). Overall, opioid prescription decreased substantially with longer time in HIV care among both episodic and chronic users.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28198711      PMCID: PMC5388582          DOI: 10.1097/QAI.0000000000001321

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

1.  The comparative safety of analgesics in older adults with arthritis.

Authors:  Daniel H Solomon; Jeremy A Rassen; Robert J Glynn; Joy Lee; Raisa Levin; Sebastian Schneeweiss
Journal:  Arch Intern Med       Date:  2010-12-13

2.  Ongoing pain despite aggressive opioid pain management among persons with HIV.

Authors:  John Koeppe; Carl Armon; Karen Lyda; Craig Nielsen; Steven Johnson
Journal:  Clin J Pain       Date:  2010 Mar-Apr       Impact factor: 3.442

3.  Chronic Pain in HIV-Infected Patients: Relationship to Depression, Substance Use, and Mental Health and Pain Treatment.

Authors:  Lisa A Uebelacker; Risa B Weisberg; Debra S Herman; Genie L Bailey; Megan M Pinkston-Camp; Michael D Stein
Journal:  Pain Med       Date:  2015-06-27       Impact factor: 3.750

4.  Prescription long-term opioid use in HIV-infected patients.

Authors:  Michael J Silverberg; Gary Thomas Ray; Kathleen Saunders; Carolyn M Rutter; Cynthia I Campbell; Joseph O Merrill; Mark D Sullivan; Caleb J Banta-Green; Michael Von Korff; Constance Weisner
Journal:  Clin J Pain       Date:  2012-01       Impact factor: 3.442

5.  Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV.

Authors:  Jessica S Merlin; Ashutosh Tamhane; Joanna L Starrels; Stefan Kertesz; Michael Saag; Karen Cropsey
Journal:  AIDS Behav       Date:  2016-03

6.  Opioid dose and drug-related mortality in patients with nonmalignant pain.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; J Michael Paterson; David N Juurlink
Journal:  Arch Intern Med       Date:  2011-04-11

7.  Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S.

Authors:  Sonia Napravnik; Joseph J Eron; Rosemary G McKaig; Amy D Heine; Prema Menezes; Evelyn Quinlivan
Journal:  AIDS Care       Date:  2006

8.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

9.  Receipt of opioid analgesics by HIV-infected and uninfected patients.

Authors:  E Jennifer Edelman; Kirsha Gordon; William C Becker; Joseph L Goulet; Melissa Skanderson; Julie R Gaither; Jennifer Brennan Braden; Adam J Gordon; Robert D Kerns; Amy C Justice; David A Fiellin
Journal:  J Gen Intern Med       Date:  2012-08-16       Impact factor: 5.128

10.  Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV.

Authors:  William C Becker; Kirsha Gordon; E Jennifer Edelman; Robert D Kerns; Stephen Crystal; James D Dziura; Lynn E Fiellin; Adam J Gordon; Joseph L Goulet; Amy C Justice; David A Fiellin
Journal:  AIDS Behav       Date:  2016-03
View more
  8 in total

Review 1.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.

Authors:  Asher J Schranz; Jessica Barrett; Christopher B Hurt; Carlos Malvestutto; William C Miller
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

2.  Longitudinal analysis of social and behavioral determinants of health in the EHR: exploring the impact of patient trajectories and documentation practices.

Authors:  Daniel J Feller; Jason Zucker; Oliver Bear Don't Walk; Michael T Yin; Peter Gordon; Noémie Elhadad
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

3.  Predictors and Consequences of Prescription Opioid Use in Women Living With and Without HIV: 20-Year Follow-Up.

Authors:  Mardge H Cohen; Lorie Benning; Kathleen M Weber; Anjali Sharma; Michael Plankey; Mirjam-Colette Kempf; Tracey E Wilson; Brad Aouizerat; Joel Milam; Adaora A Adimora; Gina Wingood; Adam W Carrico
Journal:  J Womens Health (Larchmt)       Date:  2022-02-28       Impact factor: 3.017

4.  Opioid misuse among persons with HIV engaged in care in the Southeastern US.

Authors:  Asher J Schranz; Thibaut Davy-Mendez; Joseph J Eron; Sonia Napravnik
Journal:  AIDS Care       Date:  2019-12-08

5.  HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone's Psychomotor Effects in Female Mice.

Authors:  Mohammed F Salahuddin; Fakhri Mahdi; Suresh P Sulochana; Jason J Paris
Journal:  Viruses       Date:  2021-04-30       Impact factor: 5.048

6.  Trajectories and correlates of opioid prescription receipt among patients experiencing interpersonal violence.

Authors:  Jessica R Williams; Ishrat Z Alam; Shabbar I Ranapurwala
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

7.  Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans.

Authors:  Corey J Hayes; Laura E Gressler; Bo Hu; Bobby L Jones; J Silas Williams; Bradley C Martin
Journal:  J Pain Res       Date:  2021-06-14       Impact factor: 3.133

8.  Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy.

Authors:  GYeon Oh; Emily S Brouwer; Erin L Abner; David W Fardo; Patricia R Freeman; Chris Delcher; Daniela C Moga
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.